Analyst Price Target is $7.00
▲ +136.49% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Armata Pharmaceuticals in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 136.49% upside from the last price of $2.96.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Armata Pharmaceuticals. This Buy consensus rating has held steady for over two years.